Dow Up 0.36% Nasdaq Up 0.12%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
9.82 Up 0.03(0.31%) Aug 21, 4:00PM EDT
|After Hours : 9.82 Down 0.00 (0.02%) Aug 21, 4:56PM EDT
Prev Close:9.79
Open:9.81
Bid:9.65 x 900
Ask:9.90 x 100
1y Target Est:7.67
Beta:0.53
Next Earnings Date:N/A
Day's Range:9.76 - 9.90
52wk Range:7.38 - 10.21
Volume:3,175,873
Avg Vol (3m):2,234,060
Market Cap:1.58B
P/E (ttm):5.65
EPS (ttm):1.74
Div & Yield:0.60 (6.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 0.31%1.58B
AMGNDown 0.11%100.67B
SGENDown 1.14%5.25B
XOMADown 2.56%447.58M

Key Statistics

Forward P/E (1 yr):4.38
P/S (ttm):3.20
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.14
Quarterly EPS Est (Sep-14) :0.49
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback